30383-01-8Relevant articles and documents
Erogorgiaene congeners and methods and intermediates useful in the preparation of same
-
Page/Page column 41-42, (2010/04/30)
Disclosed are compounds having the formula: wherein R21 is an alkyl, aryl, alkoxy, hydroxy, or amino group or a halogen atom; wherein R2 is hydrogen or an alkyl, aryl, alkoxy, or amino group; wherein R23 and R24 are independently selected from hydrogen, an alkyl, aryl, alkoxy, hydroxy, or amino group, and a halogen atom or wherein R23 and R24, taken together with the carbon atom to which they are bound, form a ring; wherein R25 is hydrogen, an alkyl, aryl, alkoxy, hydroxy, or O-silyl group or a halogen atom; wherein Z, taken together with the carbons to which it is bonded, forms a 5-12 membered ring; and wherein Y is an electron withdrawing group. These compounds can be used to prepare erogorgiaene congeners, such as erogorgiaene, pseudopterosin A, helioporin E, pseudopteroxazole, colombiasin A, elisapoterosin B, elisabethadione, p-benzoquinone natural products, ileabethin, sinulobtain B, sinulobtain C, and sinulobtain D.
Microwave-assisted cleavage of aryl methyl ethers with lithium thioethoxide (LiSEt)
Cvengro?, Ján,Neufeind, Stefan,Becker, Anne,Schmalz, Hans-Günther
experimental part, p. 1993 - 1998 (2009/04/07)
Lithium thioethoxide (LiSEt), a white solid easily prepared from EtSH and n-BuLi in hexane, was identified as a highly efficient reagent for the cleavage (O-demethylation) of aryl methyl ethers, i.e. methyl-protected phenols. Of particular synthetic value are applications in the double deprotection of 1,2-dimethoxyarenes (to give catechols) and in the selective monodeprotection of di- and trimethoxyarenes. The thermal reactions, which are usually performed in DMF as a solvent, can be greatly accelerated through microwave irradiation. In this case, the monodemethylated products are usually formed in high (80-99%) yield within only 15 minutes.
Benzo [B] indeno [2,1-D] thiophene compounds, intermediates, processes, compositions and methods
-
, (2008/06/13)
The invention provides benzo[b]indenothiophene compounds of formula I I wherein, R1, R2, R3, R4, R5, and R6, are as defined in the specification, intermediates, formulations, and methods of inhibiting bone loss or bone resorption, particularly ost